Search company, investor...

Predict your next investment

Venture Capital
ohioinnovationfund.com

Investments

39

Portfolio Exits

7

Funds

1

Partners & Customers

1

About Ohio Innovation Fund

Ohio Innovation Fund is a joint venture fund by Ohio University and Ohio State University.

Headquarters Location

629 North High Street 4th Floor

Columbus, Ohio, 43215,

United States

+1 614 715 2242

Want to inform investors similar to Ohio Innovation Fund about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Ohio Innovation Fund News

2023 Midwest Growth Capital Symposium to Feature Louis Cannon and Dug Song as Keynotes

Apr 18, 2023

News provided by Share this article Midwest emerging growth companies set to present in-person in Ann Arbor ANN ARBOR, Mich., April 18, 2023 /PRNewswire/ -- Organizers of the   Midwest Growth Capital Symposium (MGCS) announced today that Louis Cannon, MD, Founder and Senior Managing Director of Biostar Capital, and Dug Song, Co-Founder and President of the Song Foundation, will keynote the 2023 program. More than 300 entrepreneurs, researchers, investment professionals, and business executives are expected to attend the two-day venture investment conference. For 2023, MGCS will include panel discussions on venture capital, technology, healthcare, acquisition, and more led by industry experts, as well as presentations from high-growth Midwest ventures. Featured panelists for MGCS include: Pete Wilkins, Managing Director for Hyde Park Angels Jeff Sloan, Angel Investor, CEO of Startup Nation, CEO of Aria Ventures Alan Davis, Managing Director of Biostar Capital Jake Cohen, Partner with Detroit Venture Partners and Co-founder of Signal Advisors Chin Weerapuli, NIL Advocate for University of Michigan Athletes Michael Spath, Client Executive for Kapnick Insurance, Executive Director for A2 New Tech Ashley Williams, Founder & CEO of RIZZARR Bill Baumel, Managing Director of the Ohio Innovation Fund Dr. Tom Shehab, Managing Partner of Arboretum Ventures Jing Liu, Executive Director of the Michigan Institute for Data Science The growing ventures featured in the MGCS showcase span the life sciences, medical devices, agriculture/food, and tech industries. All featured companies will be seeking seed, Series A, or Series B funding. In addition to their on-demand virtual pitches, presenting companies will be in attendance to connect with potential investors. "The goal from the onset of the Midwest Growth Capital Symposium is to bring together private growth companies and venture capital and private equity investment firms from all parts of the country," said David Brophy, founder of the Midwest Growth Capital Symposium and University of Michigan professor emeritus. "Since the beginning of the pandemic, VCs and other investors have been searching to make good deals with cutting-edge companies. The Symposium connects these investors with growing ventures that have an early track record of success – many that lack visibility as they are based in the Midwest." The 2023 Symposium will return in person to Ann Arbor May 23 & 24. The Symposium will be held at the Ross School of Business at the University of Michigan. For more information on applying, attending, or sponsoring the symposium, please visit   www.midwestgcs.com or email Hannah Burke [email protected] . About the Midwest Growth Capital Symposium The Midwest Growth Capital Symposium (MGCS) is the original university-based venture investment fair. First held in 1980, this decades-old event is the largest Midwest venture fair of its kind that brings together venture capital investors, angel investors, high-growth companies, university tech transfer officers and research faculty. The Symposium is presented by the Zell Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business. SOURCE Midwest Growth Capital Symposium ×

Ohio Innovation Fund Investments

39 Investments

Ohio Innovation Fund has made 39 investments. Their latest investment was in Invirsa as part of their Series A on December 12, 2022.

CBI Logo

Ohio Innovation Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/30/2022

Series A

Invirsa

$5.98M

Yes

1

10/6/2022

Series C

Genetesis

$17.5M

No

10

1/27/2022

Series C

Enable Injections

$215M

No

10

9/24/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

11/12/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/30/2022

10/6/2022

1/27/2022

9/24/2021

11/12/2020

Round

Series A

Series C

Series C

Series C

Series B

Company

Invirsa

Genetesis

Enable Injections

Subscribe to see more

Subscribe to see more

Amount

$5.98M

$17.5M

$215M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

Ohio Innovation Fund Portfolio Exits

7 Portfolio Exits

Ohio Innovation Fund has 7 portfolio exits. Their latest portfolio exit was Complion on December 07, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/7/2022

Acquired

$99M

5

1/11/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

3/22/2021

Merger

Subscribe to see more

$99M

Subscribe to see more

10

6/4/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/3/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/7/2022

1/11/2022

3/22/2021

6/4/2020

6/3/2020

Exit

Acquired

Acquired

Merger

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

10

Ohio Innovation Fund Fund History

1 Fund History

Ohio Innovation Fund has 1 fund, including Ohio Innovation Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/10/2017

Ohio Innovation Fund

$5M

1

Closing Date

5/10/2017

Fund

Ohio Innovation Fund

Fund Type

Status

Amount

$5M

Sources

1

Ohio Innovation Fund Partners & Customers

1 Partners and customers

Ohio Innovation Fund has 1 strategic partners and customers. Ohio Innovation Fund recently partnered with ConnXus on August 8, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

8/16/2018

Partner

United States

Ohio Innovation Fund Adds ConnXus to its Portfolio of Emerging Ohio Companies - Cloud-Based Supplier Management Solutions

`` Ohio Innovation Fund 's partners GET software , '' said Rod Robinson , Founder and CEO of ConnXus , Inc. .

1

Date

8/16/2018

Type

Partner

Business Partner

Country

United States

News Snippet

Ohio Innovation Fund Adds ConnXus to its Portfolio of Emerging Ohio Companies - Cloud-Based Supplier Management Solutions

`` Ohio Innovation Fund 's partners GET software , '' said Rod Robinson , Founder and CEO of ConnXus , Inc. .

Sources

1

Ohio Innovation Fund Team

1 Team Member

Ohio Innovation Fund has 1 team member, including current Managing Director, Bill Baumel.

Name

Work History

Title

Status

Bill Baumel

RWI Ventures, Coral Group, Procter & Gamble, and Deloitte

Managing Director

Current

Name

Bill Baumel

Work History

RWI Ventures, Coral Group, Procter & Gamble, and Deloitte

Title

Managing Director

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.